In a series of recent single and multiple dose investigational studies that were designed to assess the safety and toxicity of a particular growth factor, we noticed a higher than normal bound incidence of megakaryocytic neutrophilic emperipolesis in the bone marrows of male and female CD-1 (Cr 1: CD-1 1 (ICR)BR) mice. Emperiopolesis is the active penetration of one cell, typically a megakaryocyte, by another; it differs from phagocytosis in that the entering cell only temporarily resides within the host cell, remaining viable and retaining an intact normal cell structure during its stay (2, 5) . Although emperiopolesis does not appear to have been described in mice in the literature, it has been documented in rats and man (1, 2, (4) (5) (6) (7) (8) . In mice and rats, neutrophils appear to be the most common type of blood cell observed within megakaryocytes (5) . In our studies, neutrophilic emperipolesis was observed in treated and control mice alike. Although the cause of emperipolesis is unknown, it has been associated with hematopoietic cell hyperplasia secondary to chronic blood loss and/or chronic inflammation (3, 4) . Additionally, it has been associated with increased megakaryocytic turnover or death (3, 4) . Although the etiology and significance of emperipolesis in the CD-1 mice of these studies was unclear, it is worth noting that spontaneous emperipolesis does occur in CD-1 mice, and will occasionally appear in clearly noticeable proportions.
